Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nanalysis Scientific Corp. V.NSCI

Alternate Symbol(s):  NSCIF

Nanalysis develops and manufactures compact MRI and NMR devices for clinical, laboratory, and industrial markets. These portable devices require no liquid helium or any other cryogens. The company’s devices are used in diagnostics and chemical analysis across a range of industries (medical, pharma, biotech, mining, oil and gas, and more) as well as numerous government and university research labs around the world.


TSXV:NSCI - Post by User

Comment by GoldenArmon May 26, 2022 4:01pm
210 Views
Post# 34710183

RE:RUN to 💲2️⃣

RE:RUN to 💲2️⃣That is a very conservative number. They are heading for 100% increase in sales just from the NMR unit and not the have a 30M+/yr contract. If they can use the contract to sell more equipment it could mean a lot more. Are we now looking at revenue to come in at $64M for 2022 (let me know if that is wrong and I'm basing this on the company saying they expect revenues to increase from sale by 100%)

If this is correct they should be $3 a share soon.


<< Previous
Bullboard Posts
Next >>